[Effect of alpha-methyl-paratyrosine on the urinary excretion of catecholamines in patients with pheochromocytoma].
D000293:Adolescent; D000310:Adrenal Gland Neoplasms / Q000188:drug therapy / Q000652:urine*; D000328:Adult; D002395:Catecholamines / Q000652:urine*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology* / Q000627:therapeutic use; D010673:Pheochromocytoma / Q000188:drug therapy / Q000652:urine*; D013565:Sympatholytics / Q000627:therapeutic use; D019805:alpha-Methyltyrosine
D002395:Catecholamines; D008781:Methyltyrosines; D013565:Sympatholytics; D019805:alpha-Methyltyrosine
Efecto de la alfa-metil-paratirosina sobre la excreción urinaria de catecolaminas en pacientes con feocromocitoma.